American Federation of Government Employees Local 1916
|
American Federation of Government Employees Local 1916
|
|
|
Coalition of Labor Union Women
The Food and Drug Administration (FDA) announced on June 8 its expedited approval for the first vaccine against human papillomavirus -- HPV -- the viruses that cause cervical cancer and genital warts. The vaccine prevents infection with HPV types 6, 11, 16 and 18. HPV types 6 and 11 cause about 90 percent of genital warts. HPV types 16 and 18 cause about 70 percent of cervical cancers.
Approval opens the door for new programs to reduce cervical cancer among women in the United States and around the world. The vaccine, named Gardasil, was developed by Merck & Co.
An expanded version of this appears on the Cervical Cancer Prevention Works section of the CLUW website.
Visit the web address below to tell your
friends about this. If you received this message from a friend, you can sign up for CLUW.
This message was sent to wrightfwright@aol.com. Visit your subscription management page to modify your email communication preferences or update your personal profile. To stop ALL email from CLUW, click to remove yourself from our lists (or reply via email with "remove" in the subject line). |
|
|
||||
